Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Price-to-earnings ratio
Latest
141.40
↑ 2977% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
4.60
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 141.40 | +807.7% |
| 2024 | -19.98 | -48.7% |
| 2023 | -13.44 | -59.7% |
| 2022 | -8.41 | -57.3% |
| 2021 | -5.35 | +57.1% |
| 2020 | -12.47 | -99.4% |
| 2019 | -6.25 | -11.1% |
| 2018 | -5.63 | +61.4% |
| 2017 | -14.56 | -55.6% |
| 2016 | -9.36 | - |